NCT00364091View on ClinicalTrials.gov

Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis

PHASE3CompletedINTERVENTIONAL
Enrollment

365

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

October 31, 2006

Conditions
Allergic Conjunctivitis
Interventions
DRUG

R89674 0.025% ophthalmic solution

Trial Locations (6)

Unknown

Louisville

North Andover

Creve Coeur

Charlotte

Philadelphia

Memphis

All Listed Sponsors
lead

Vistakon Pharmaceuticals

INDUSTRY

NCT00364091 - Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis | Biotech Hunter | Biotech Hunter